N99.83
Residual ovary syndrome
Clinical Classification Guidelines
Medical Intelligence & Overview
Residual Ovary Syndrome (ROS) is a condition that can occur after pelvic surgeries involving the removal of reproductive organs. It is characterized by the persistence of ovarian tissue after procedures such as hysterectomy or oophorectomy. This residual tissue may continue to produce hormones, leading to various symptoms and associated health considerations. Recognizing and understanding ROS is important for patients and healthcare providers to manage symptoms effectively and monitor overall reproductive health.
Causes & Symptoms
Clinical Causes: Incomplete removal of ovarian tissue during pelvic surgery Surgical technique variations leading to residual ovarian tissue Regrowth of ovarian tissue after surgery Presence of micropolyps or small ovarian remnants that are not removed during surgery
Key Symptoms: Pelvic pain or discomfort Irregular or resumed menstrual bleeding in women who had hysterectomy Hormonal symptoms such as hot flashes, night sweats, or mood swings Pelvic mass or swelling detected during physical exams Persistent or recurrent ovarian cysts Potential fertility issues if ovarian tissue remains functional
Diagnostic & Treatment
Diagnosis Path: Diagnosis of Residual Ovary Syndrome typically involves a combination of medical history review, physical examination, and imaging studies such as ultrasound or MRI. These imaging techniques help visualize any remaining ovarian tissue. Blood tests measuring hormone levels may also assist in assessing ovarian activity. Accurate diagnosis aims to distinguish ROS from other pelvic or ovarian conditions, ensuring appropriate management plans.
Treatment Protocols: Management strategies depend on the severity of symptoms and the patient's overall health goals. Options may include the surgical removal of residual ovarian tissue if symptomatic or problematic. Hormonal therapy may be considered to balance hormone levels if residual tissue causes hormonal imbalances. Regular monitoring might be recommended for asymptomatic cases to observe any changes over time. Collaboration with a healthcare professional is essential to determine the most suitable approach for each individual.
Clinical Advice & FAQs
Billing Guidance
Is N99.83 a billable ICD-10 code?
Yes, N99.83 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N99.83?
Clinical documentation must specify the nature of Residual ovary syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference